Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1994 2
1995 3
1999 1
2000 1
2002 1
2004 2
2005 1
2006 1
2007 2
2008 1
2009 1
2010 3
2011 7
2012 6
2013 8
2014 7
2015 10
2016 4
2017 3
2018 5
2019 15
2020 14
2021 30
2022 29
2023 23
2024 21
2025 21

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

202 results

Results by year

Filters applied: . Clear all
Page 1
Author response.
Ip A, Black G, Vindrola C, Taylor C, Otter S, Hewish M, Bhuiya A, Callin J, Wong A, Machesney M, Fulop NJ, Taylor C, Whitaker KL. Ip A, et al. Br J Gen Pract. 2022 Jul 28;72(721):372-373. doi: 10.3399/bjgp22X720245. Print 2022 Aug. Br J Gen Pract. 2022. PMID: 35902248 Free PMC article. No abstract available.
The authors reply.
Ng PY, Ng AK, Ip A, Yiu KH. Ng PY, et al. Among authors: ip a. Crit Care Med. 2023 Sep 1;51(9):e186-e187. doi: 10.1097/CCM.0000000000005946. Epub 2023 Aug 17. Crit Care Med. 2023. PMID: 37589525 No abstract available.
Comparisons of treatment outcomes of epcoritamab versus chemoimmunotherapy, polatuzumab-based regimens, tafasitamab-based regimens, or chimeric antigen receptor T-cell therapy, in third-line or later relapsed/refractory large B-cell lymphoma.
Rosenthal A, Munoz J, Jun M, Wang T, Mutebi A, Wang A, Yang S, Osei-Bonsu K, Elliott B, Rivas Navarro F, Yu J, Brodkin S, Sacchi M, Ip A. Rosenthal A, et al. Among authors: ip a. J Hematol Oncol. 2024 Aug 16;17(1):69. doi: 10.1186/s13045-024-01594-x. J Hematol Oncol. 2024. PMID: 39152509 Free PMC article.
An inflammatory biomarker signature of response to CAR-T cell therapy in non-Hodgkin lymphoma.
Raj SS, Fei T, Fried S, Ip A, Fein JA, Leslie LA, Alarcon Tomas A, Leithner D, Peled JU, Corona M, Dahi PB, Danylesko I, Epstein-Peterson Z, Funnell T, Giralt SA, Jacoby E, Kedmi M, Landego I, Lin RJ, Parascondola A, Pascual L, Orozco N, Park JH, Palomba ML, Salles G, Saldia A, Schöder H, Sdayoor I, Shah GL, Scordo M, Shem-Tov N, Shimoni A, Slingerland J, Yerushalmi R, Nagler A, Greenbaum BD, Vickers AJ, Suh HC, Avigdor A, Perales MA, van den Brink MRM, Shouval R. Raj SS, et al. Among authors: ip a. Nat Med. 2025 Apr;31(4):1183-1194. doi: 10.1038/s41591-025-03532-x. Epub 2025 Apr 1. Nat Med. 2025. PMID: 40169864 Free PMC article.
Comparative real-world outcomes of CD19-directed CAR T-cell therapies in large B-cell lymphoma.
Deschênes-Simard X, Bromberg M, Devlin SM, Gonen M, Beyar-Katz O, Ip A, Marcus R, Avigdor A, Ballweg A, Rabinovich E, Alhomoud M, Rivas Delgado A, Corona De Lapuerta M, Luna De Abia A, Palomba ML, Shah GL, Lin R, Boardman AP, Falchi L, Lue J, Salles G, Perales MA, Shouval R, Dahi PB, Scordo M. Deschênes-Simard X, et al. Among authors: ip a. Blood Adv. 2025 Nov 11;9(21):5571-5584. doi: 10.1182/bloodadvances.2025016778. Blood Adv. 2025. PMID: 40815804
Autism Risk and Perinatal Antibiotic Use.
Nitschke AS, Karim JL, Vallance BA, Bickford C, Ip A, Lanphear N, Lanphear B, Weikum W, Oberlander TF, Hanley GE. Nitschke AS, et al. Among authors: ip a. Pediatrics. 2022 Sep 1;150(3):e2022057346. doi: 10.1542/peds.2022-057346. Pediatrics. 2022. PMID: 36017659
Subsequent Malignancies After CD19-Targeted Chimeric Antigen Receptor T Cells in Patients With Lymphoma.
Lorenc R, Shouval R, Flynn JR, Devlin SM, Saldia A, De Abia AL, De Lapuerta MC, Tomas AA, Cassanello G, Leslie LA, Rejeski K, Lin RJ, Scordo M, Shah GL, Palomba ML, Salles G, Park J, Giralt SA, Perales MA, Ip A, Dahi PB. Lorenc R, et al. Among authors: ip a. Transplant Cell Ther. 2024 Oct;30(10):990-1000. doi: 10.1016/j.jtct.2024.06.027. Epub 2024 Jul 6. Transplant Cell Ther. 2024. PMID: 38972512 Free PMC article.
Outcomes of CD19 CAR-T therapy in central nervous system lymphoma: Insights from a multicentre experience.
Cassanello G, Luttwak E, Brown S, Devlin SM, Imber B, Ip A, Leslie LA, Accav NG, Avigdor A, Marcus R, Beyar-Katz O, Corona M, Luna De Abia A, Calabrese De Feo J, Rivas Delgado A, Lue JK, Grommes C, Shah GL, Park J, Perales MA, Salles G, Shouval R, Scordo M, Palomba ML. Cassanello G, et al. Among authors: ip a. Br J Haematol. 2025 Aug;207(2):525-534. doi: 10.1111/bjh.20234. Epub 2025 Jul 1. Br J Haematol. 2025. PMID: 40589238
Updates on the Biological Heterogeneity of Mantle Cell Lymphoma.
Ip A, Kabat M, Fogel L, Alkhatatneh H, Voss J, Gupta A, Della Pia A, Leslie LA, Feldman T, Albitar M, Goy AH. Ip A, et al. Cancers (Basel). 2025 Feb 19;17(4):696. doi: 10.3390/cancers17040696. Cancers (Basel). 2025. PMID: 40002289 Free PMC article. Review.
Updates in the Treatment of Post-Stroke Pain.
Plecash AR, Chebini A, Ip A, Lai JJ, Mattar AA, Randhawa J, Field TS. Plecash AR, et al. Among authors: ip a. Curr Neurol Neurosci Rep. 2019 Nov 13;19(11):86. doi: 10.1007/s11910-019-1003-2. Curr Neurol Neurosci Rep. 2019. PMID: 31720885 Review.
202 results